BMC Biology (Sep 2022)

Combined protein and transcript single-cell RNA sequencing in human peripheral blood mononuclear cells

  • Jenifer Vallejo,
  • Ryosuke Saigusa,
  • Rishab Gulati,
  • Sujit Silas Armstrong Suthahar,
  • Vasantika Suryawanshi,
  • Ahmad Alimadadi,
  • Christopher P. Durant,
  • Yanal Ghosheh,
  • Payel Roy,
  • Erik Ehinger,
  • Tanyaporn Pattarabanjird,
  • David B. Hanna,
  • Alan L. Landay,
  • Russell P. Tracy,
  • Jason M. Lazar,
  • Wendy J. Mack,
  • Kathleen M. Weber,
  • Adaora A. Adimora,
  • Howard N. Hodis,
  • Phyllis C. Tien,
  • Igho Ofotokun,
  • Sonya L. Heath,
  • Avishai Shemesh,
  • Coleen A. McNamara,
  • Lewis L. Lanier,
  • Catherine C. Hedrick,
  • Robert C. Kaplan,
  • Klaus Ley

DOI
https://doi.org/10.1186/s12915-022-01382-4
Journal volume & issue
Vol. 20, no. 1
pp. 1 – 19

Abstract

Read online

Abstract Background Cryopreserved peripheral blood mononuclear cells (PBMCs) are frequently collected and provide disease- and treatment-relevant data in clinical studies. Here, we developed combined protein (40 antibodies) and transcript single-cell (sc)RNA sequencing (scRNA-seq) in PBMCs. Results Among 31 participants in the Women’s Interagency HIV Study (WIHS), we sequenced 41,611 cells. Using Boolean gating followed by Seurat UMAPs (tool for visualizing high-dimensional data) and Louvain clustering, we identified 50 subsets among CD4+ T, CD8+ T, B, NK cells, and monocytes. This resolution was superior to flow cytometry, mass cytometry, or scRNA-seq without antibodies. Combined protein and transcript scRNA-seq allowed for the assessment of disease-related changes in transcriptomes and cell type proportions. As a proof-of-concept, we showed such differences between healthy and matched individuals living with HIV with and without cardiovascular disease. Conclusions In conclusion, combined protein and transcript scRNA sequencing is a suitable and powerful method for clinical investigations using PBMCs.

Keywords